Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination therapy with gefitnib and capecitabine in metastatic breast cancer (MBC): A phase I trial

Combination therapy with gefitnib and capecitabine in metastatic breast cancer (MBC): A phase I trial. Proc Am Soc Clin Oncol. 2006; (abstr 10564).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.